Mostrando 10 resultados de: 12
Publisher
ChemMedChem(3)
2007 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2007, Technical Proceedings(2)
ACS Nano(1)
Expert Opinion on Drug Delivery(1)
Handbook of Experimental Pharmacology(1)
Área temáticas
Farmacología y terapéutica(11)
Enfermedades(5)
Fisiología y materias afines(2)
Ingeniería y operaciones afines(2)
Medicina y salud(2)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(12)
ODS 9: Industria, innovación e infraestructura(11)
ODS 17: Alianzas para lograr los objetivos(1)
Origen
scopus(12)
HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy
ArticleAbstract: (Figure Presented) Affibodies are a class of polypeptide ligand that are potential candidates for tiPalabras claves:Affibodies, Antitumor agents, Nanoparticles, PLA-PEG copolymers, Targeted therapyAutores:Basto P.A., Farokhzad O.C., Frank Alexis, Levy-Nissenbaum E., Marein S.L., Molnar L.K., Pridgen E.M., Radovic-Moreno A.F., Wang A.Z., Westerhof K., Zhang L.Fuentes:scopusEngineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection
ArticleAbstract: Figure Persented: One of the major challenges in the development of targeted nanoparticles (NPs) forPalabras claves:aptamer, in vitro selection, Internalization, Nanoparticles, targeted cancer therapyAutores:Chan J.M., Cheng J., Digga E., Farokhzad O.C., Frank Alexis, Langer R.S., Levy-Nissenbaum E., Lupták A., Shi J., Teply B.A., Xiao Z.Fuentes:scopusCo-delivery of hydrophobic and hydrophilic drugsfrom nanoparticle-aptamer bioconjugates
ArticleAbstract: (Figure Presented) Herein we report a novel targeted drug delivery system consisting of nanoparticlePalabras claves:Antitumor agents, conjugation, Dual drug delivery, Nanoparticles, Targeted therapyAutores:Bagalkot V., Basto P.A., Farokhzad O.C., Frank Alexis, Gu F.X., Jon S., Langer R.S., Radovic-Moreno A.F., Zhang L.Fuentes:scopusAdjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release
ArticleAbstract: Augmentation of immunogenicity can be achieved by particulate delivery of an antigen and by its co-aPalabras claves:adjuvant, CpG, R848, Resiquimod, Synthetic nanoparticle vaccine, TLR agonistAutores:Altreuter D.H., Basto P.A., Browning E.A., Farokhzad O.C., Frank Alexis, Iannacone M., Ilyinskii P.O., Johnston L.P.M., Kishimoto T.K., Langer R.S., O'Neil C.P., Pittet L.A., Radovic-Moreno A.F., Roy C.J., Shi J., Tonti E., von Andrian U.H.Fuentes:scopusPolymeric nanoparticle drug delivery technologies for oral delivery applications
ReviewAbstract: Introduction: Many therapeutics are limited to parenteral administration. Oral administration is a dPalabras claves:chemotherapy, Inflammatory bowel disease, Insulin, M cells, mucoadhesives, mucosal vaccinations, oral delivery, Polymeric nanoparticles, transcytosisAutores:Farokhzad O.C., Frank Alexis, Pridgen E.M.Fuentes:scopusSuperparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy
ArticleAbstract: (Chemical Equation Presented) Multifunctional superparamagnetic iron oxide nanoparticles: Herein wePalabras claves:doxorubicin, Nanoparticles, Superparamagnetic, TCL-SPIONAutores:Bagalkot V., Bander N.H., Cima M.J., Farokhzad O.C., Frank Alexis, Gu F.X., Jon S., Kantoff P.W., Langer R.S., Shaikh M., Vasilliou C.C., Wang A.Z., Yuet K., Zhang L.Fuentes:scopusNanoparticle technologies for cancer therapy
ReviewAbstract: Nanoparticles as drug delivery systems enable unique approaches for cancer treatment. Over the lastPalabras claves:cancer therapy, drug delivery, Metastatic cancer, Nanoparticle, TargetedAutores:Farokhzad O.C., Frank Alexis, Langer R.S., Pridgen E.M.Fuentes:scopusNew frontiers in nanotechnology for cancer treatment
ReviewAbstract: Nanotechnology is a field of research at the crossroads of biology, chemistry, physics, engineering,Palabras claves:Cancer diagnosis, cancer therapy, Nanocarriers, Targeting moleculesAutores:Farokhzad O.C., Frank Alexis, Langer R.S., Radovic-Moreno A.F., Rhee J.W., Richie J.Fuentes:scopusTargeted aptamer-nanoparticles to diminish drug resistance of cancer cells in vitro study
Conference ObjectAbstract: Using prostate cancer as a model, we report the drug release of Docetaxel and doxorubicin from aptamPalabras claves:aptamer, doxorubicin, Poly (D,L-lactic-co-glycolic acid) (PLGA), Prostate cancer, Targeted deliveryAutores:Basto P.A., Farokhzad O.C., Frank Alexis, Langer R.S., Zhang L.Fuentes:scopusTargeted nanoparticle-polypeptide bioconjugates for breast cancer therapy
Conference ObjectAbstract: Novel approaches that allow for a more effective and less toxic chemotherapy for disseminated breastPalabras claves:Docetaxel, HER2, Pla, Poly (lactic acid), Targeted nanoparticlesAutores:Basto P.A., Farokhzad O.C., Frank Alexis, Gu F.X., Langer R.S., Levy-Nissenbaum E., Radovic-Moreno A.F.Fuentes:scopus